ABSTRACT. In poultry, the benefits of probiotic supplementation on broiler performance and health have been reported. The present study examined the effect of supplemental yeast probiotic preparations on body weight, thyroid hormone metabolism and serum lipid profile in broilers. The experiment was carried out on hybrid Marshall broiler chickens (n=200). Two hundred 1-day-old chicks were randomly selected and distributed into 4 groups of 50 1-day-old chicks each (control, C; E 1 0.5%, E 2 1.5% and E 3 2.0%, experimental groups). The birds were housed in an environmentally controlled poultry house with the floor covered with wood shavings. Chicks were fed commercial broiler starter diet for the first 28 days of age, followed by pelleted finisher diet from 29-42 days. Feed and water were provided ad libitum. Chickens fed 2.0% probiotic had a significantly (P<0.05) higher body weight when compared with the control group. The blood glucose concentration was significantly (P<0.05) different in the E 3 1.5% probiotic supplemented group when compared with the control. There was highly significant (P<0.05) difference in T 4 level in the E 3 2.0% probiotic group when compared with the control. However, there was a significant difference in cholesterol concentrations observed in the experimental group supplemented with E 1 0.5% probiotic. The concentration of triglycerides was not affected by the probiotic supplementation. Significant differences (P<0.01) were observed in HDL concentrations in all experimental groups supplemented with the probiotic when compared with the control group. In conclusion, supplementing broiler feeds with a yeast probiotic increased body weight, enhanced thyroid hormone metabolism, and decreased cholesterol and lipoproteins in broiler chickens.
Probiotics are live microbial feed supplements that beneficially affect the host by improving its intestinal microbial balance [16] . They are viable single or mixed cultures of microorganisms that when given to animals or humans, beneficially affect the host by improving the properties of the indigenous microflora [28, 29, 34] . The probiotic, Saccharomyces cerevisiae, is one of the live microorganisms that, when administered through the digestive tract, has a positive impact on the host health through its direct nutritional effect. Probiotics act by reducing feed conversion, resulting in an increase in daily live weight gain [38] . Nonantibiotic growth promoters, such as organic acids and probiotics, are already well established in animal nutrition [60] . They have been used as an alternative to antibiotics in animals and humans, and their efficiency in animals has been well established [39, 43, 56] .
Manjapra et al. [32] demonstrated that the yeast Saccharomyces cerevisiae is an excellent system in which to study thyroid hormone receptor (TR) action. The identification of TR co-regulators has enhanced the understanding of thyroid hormone action; however, it is likely that many other coregulators remain unidentified, and unbiased methods are required in order to discover these co-regulators [32] . In chickens, the plasma levels of thyroid hormones are affected by the ambient temperature, age, feeding status and pathophysiologic status [11, 12, 30, 31, 57] . Triiodothyronine (T 3 ) affects a multitude of physiological processes in mammals such as development, regulation of body temperature and metabolism of lipids and carbohydrates [61] . T 3 binds to the thyroid hormone receptors (TRs) with much higher affinity compared with thyroxine (T 4 ), which is considered to be a prohormone [51] . T 3 plays an important role in the homeostasis of cholesterol in the vascular endothelium. Thyroid hormone plays an important function in regulating various processes in the liver, including the regulation of triglycerides, cholesterol metabolism and lipoprotein homeostasis as well as the induction of genes involved in glycolysis and gluconeogenesis [62] . Most recently, considerable attention has been paid to testing the potency of growth promoters in altering lipid profile metabolism; excess fat deposition is undesirable in the human body because it always results in fatal diseases like atherosclerosis and stroke. Previous studies revealed that probiotics reduced the level of cholesterol in broilers [23, 36] . Pandal et al. [41] reported that probiotics caused a reduction in the level of serum and yolk cholesterol and also increased egg production. Probiotic supplementation may also depress the concentration of cholesterol in blood and yolk of chickens [35] . Gilliland et al. [20] hypothesized that some Lactobacillus spp are able to incorporate cholesterol into the cellular membrane of the organism; thus, cholesterol assimilation by Lactobacillus spp in turn reduces cholesterol absorption in the system. Based on this background, the main aim of the study was to investigate the effect of different levels of supplemental yeast on weight gain, thyroid hormone metabolism and lipid profile of broiler chickens. We hypothesized that different levels of supplemental probiotic in poultry feeds may increase performance indices, thyroid hormone metabolism and lipid profile of blood of broiler chickens.
MATERIALS AND METHODS

Experimental design and animal management:
The experiment was carried out on hybrid Marshall broiler chickens (n=200). Two hundred 1-day-old chicks were randomly selected and distributed into 4 groups of 50 1-day-old chicks each (control, C; E 1 0.5%, E 2 1.5% and E 3 2.0% yeast probiotic experimental groups). The birds were housed in an environmentally controlled poultry house with the floor covered with wood shavings. The shavings were kept dry throughout the experimental period by routine replacement of the spoiled litter. Chicks were administered the Newcastle disease vaccine (NDV-intraocular), infectious bursal disease vaccine (IBDV) and Newcastle disease vaccine (NDV-La Sota) on days 3, 14 and 21, respectively. The feeding lasted 42 days, and the yeast was added to the feed at the dosage of 500 g/1,000 kg of feed. The yeast was a mixed probiotic containing Saccharomyces cerevisiae and Lactobacillus sporogenes at 1.5 × 10 8 CFU and 5.0 × 10 8 CFU per gram, respectively, grown Soyabean and CFD, fortified with phytase and rich in calcium, phosphorus, proteins, carbohydrates, vitamins and UGF, nonantibiotic, non-chemotherapeutic bio-growth promoter. Chicks were fed commercial broiler starter diet for the first 28 days of age and pelleted finisher diet from 29-42 days of age. Birds had 15 hr of light and 9 hr of darkness throughout the experimental period. Ingredient and nutrient compositions of diets and proximate analysis of diets and the probiotic are all shown in Tables 1 and 2 , respectively. Feed and water were provided ad libitum. Body weight (BW), feed conversion ratio (FCR), feed intake (FI) and mortality were recorded on a weekly basis for comparative evaluation and interaction effects of all treatment groups. After 42 days of feeding, blood was collected after 5 hr of fasting from 10 randomly selected broiler chickens from each group through the brachial vein into polythene tubes.
Body weight measurement: Birds were weighed individually at weekly intervals using a Mettler Toledo ® digital precision weighing balance with a sensitivity of 0.01g (Model MT-500D), and the body weights were recorded to calculate body weight gains.
Carcass and organ weight measurement: Ten fasted broiler chickens from a total of 50 birds per experimental group were randomly selected, and each was reweighed just before slaughtering. Immediately after stunning in an electrobath, the birds were slaughtered by severing the jugular vein. After evisceration, the abdominal fat was collected and weighed. Eviscerated carcasses and organs were individually weighed using a Mettler Toledo ® digital precision weighing balance.
Thyroid function test and blood glucose determination: Thyroid function test (TFT) was performed on serum by the method of Young et al. [64] to measure triiodothyronine (T 3 ), thyroxine (T 4 ) and thyroid stimulating hormone (TSH) levels using a Bio-Rad ELISA Microplate Reader (PR 5100). The fasting blood glucose level was determined in serum by the glucose oxidase method [58] .
Serum cholesterol and triglyceride assay: Serum was collected by first allowing the blood to clot, followed by centrifugation at 2,000 × g for 15 min. Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-cholesterol) and triglyceride (TG) were determined in serum by colorimetric methods of Allain et al. [1] , Burstein et al. [9] and Trinder [58] , respectively, using enzymatic diagnostic kits (AGAPPE Diagnostic Switzerland GmbH). Low-density lipoprotein cholesterol (LDL-cholesterol) was calculated according to the formula of Friedewald et al. [14] :
Statistical analysis: GraphPad Windows 4.03 (GraphPad Software, San Diego, CA, U.S.A.) was used for statistical analyses and data obtained were expressed as the mean ± standard error of the mean (Mean ± SEM). Data were analyzed using repeated measures ANOVA. Dunnett's post hoc test was used to compare all experimental groups with the control. Values of P<0.05 were considered significant. Table 3 . Body weights from week 4 in the E 3 2.0% probiotic supplemented group differed significantly (P<0.01) when compared with the control. In the 5th week, body weights differed significantly (P<0.05) in the E 1 0.5 and E 3 2.0% probiotic supplemented groups, respectively, when compared with the control group. The body weights of broiler chickens from weeks 1 to 3 did not differ (P>0.05) when compared with that of the control group. Overall, the body weight obtained in the E 3 2.0% probiotic supplementation group at Table 4 . Feed intake in the E 2 1.5% group was significantly (P<0.05) different when compared with that of the control group during the first 21 days. Generally, there was no significant (P>0.05) difference in feed intake among the experimental groups when compared with the control group from day 28 to 42 of the experimental period.
RESULTS
Body weight of broiler chickens: Results are shown in
Carcass and organ weights of broiler chickens:
Carcass and organ weight results are presented in Table 5 . Broiler chickens in the E 3 2.0% group were heavier than those in the E 2 1.5% group. Both the E 3 and E 2 groups were significantly (P<0.01) heavier when compared with the control (C). The gizzard, heart, liver, and the lungs in the E 2 and E 3 groups were significantly (P<0.01) heavier when compared with the control group. The weight of the proventriculus in the E 3 group was significantly (P<0.01) higher when compared with the control. Also, the weights of the thighs and drum sticks in the E 3 group were significantly heavier (P<0.05 and P<0.01, respectively) when compared with the control group. Blood glucose and thyroid hormones: Blood glucose concentrations and thyroid hormone titers are shown in Table 6 . The blood glucose concentration was significantly different (P<0.05) in the experimental E 3 1.5% probiotic supplementation group when compared with the control. Thyroxine, T 4 , levels differed significantly (P<0.01) in the experimental groups E 1 0.5 and E 2 1.5% probiotic supplemented groups when compared with the control. There was a highly significant difference in T 4 level (P<0.05) in the third experimental, E 3 2.0% probiotic group when compared with the control. The thyroid stimulating hormone (TSH) level was significantly different (P<0.01) in the experimental E 2 1.5 group, and a highly significant difference (P<0.05) was observed in the E 3 2.0% probiotic supplemented group when compared with the control.
Serum cholesterol and triglycerides:
The concentrations of serum cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol are presented in Table 7 . Significant differences (P<0.01) were observed in the concentrations of HDL-cholesterol in all experimental groups supplemented with probiotic when compared with the control group. There was no significant difference in the concentrations of LDL in all the groups when compared with the control. However, there was a significant difference in the cholesterol concentrations observed in the experimental group supplemented with E 1 0.5% probiotic. The concentration of triglycerides did not differ due to probiotic supplementation.
DISCUSSION
Body weight of broiler chickens:
The result showed that probiotic supplementation had no effect on body weight of broiler chickens from the 1st week to 3rd week of life. This may be due to the time it took for the probiotic to reestablish the conditions of eubiosis in the digestive tract. However, from the 4th to 6th week, body weight differed significantly between the control and E 1 and E 3 experimental groups, but not between the control and the second experimental group (E 2 ). Overall, the highest body weight was recorded in the experimental group with the highest probiotic concentration (E 3 2.0%). This was made possible by the decrease in FCR, enhanced intestinal absorptive area through increased villi length and added gut mucosa antigenic response. This finding is in agreement with previous studies conducted by Midilli and Tuncer [33] and Piray et al. [45] in which increases in body weights were reported in broilers fed diets supplemented with probiotics and prebiotics, respectively. Also, this result demonstrated that probiotic supplementation has a more positive effect on body weight when administered in higher concentrations. Santin et al. [52] showed that cell walls of Saccharomyces cerevisiae improve nutrient absorption from the intestinal mucosa and suggested that this factor may be responsible for the improvement in performance of broilers supplemented with Saccharomyces cerevisiae. Probiotics act by reducing feed conversion, resulting in an increase of daily live weight gain [6, 38] . This is achieved through a natural, physiological way, improving digestion by balancing the resident gut microflora. Essentially, they help the animal to fulfil its genetic potential. The significant de- [65] .
Feed intake of broiler chickens:
The improvement in feed intake by dietary probiotic and prebiotic supplementation often resulted in improved growth performance. In the present study, though there was no significant difference in feed intake between treated birds and control birds, birds fed the dietary yeast supplement had a significantly (P<0.01) higher live weight at day 42 (week 6) of the experiment. The improvement in live weight is attributable to improved digestion and absorption of nutrients in the digestive tract due to the presence of live yeast cells of Saccharomyces cerevisiae. The results of the present study are in agreement with the findings of Sims and Sefton [63] and Yeo and Kyuil [55] , who reported that dietary additions of prebiotics, probiotics and organic acid preparations, respectively, did not affect feed intake of broiler chickens. However, a series of experimental studies revealed that dietary probiotics [49] and prebiotics [50] increase feed intake in broiler chickens.
Carcass and organ weights of broiler chickens:
The differences in carcass weights of broiler chickens may originate from differences in feed conversion ratio, because there was generally no significant difference in feed intake in all the experimental groups when compared with the control group. Nevertheless, the birds that were fed 2.0% probiotic (E 3 ) were, to some extent, heavier than those in the E 2 group (1.5% probiotic) and were heavier when compared with the control group. In the present study, the yeast probiotic in the E 3 group was the most effective in elevating the live weight of broiler chickens followed by that in the E 2 probiotic group. These two experimental groups (E 2 and E 3 ) appeared to manifest a dose-weight response treatment trend. This is evidenced from the weights of the organs like the gizzard, liver, heart, lungs, crop and proventriculus in the E 2 and E 3 groups, respectively. On the contrary, Pelicano et al. [44] reported lower pre-slaughter weights of animals treated with Bacillus subtilis in comparison with chickens fed multi-strain probiotic (Lactobacillus streptococcus, Bifidobacterium, Aspergillus) feed. Abdominal fat represents the main fat deposition in broiler chickens, and it seems to be directly related to total carcass fat (Santoso et al. [53] , Gaya et al. [17] ). Excess accumulation of abdominal fat means both processing and waste problems, but also indicates inefficient feed energy use [21] . In the present study, we observed significant differences in abdominal fat in probioticsupplemented groups. The higher the level of yeast probiotic supplementation, the lower the quantity of abdominal fat.
Several studies reported lowering of abdominal fat by probiotic addition (Santoso et al. [53] , Homms and Shinohara [21] , Anjum et al. [2] , Safalaoh [49] ).
Blood glucose and thyroid hormones: The probioticsupplemented groups did not differ in the blood glucose levels, but there was a significant difference between the control group and the (E 2 1.5%) supplemented group. This may be due to the suppressive effect of the probiotic on glucagons, which increases blood glucose in chickens, thereby maintaining blood glucose homeostasis. The present result concerning the blood glucose concentration is in agreement with the findings in rats of Klieverik et al. [26] , who showed that the genomic effects of T 3 on hepatic glucose metabolism occur via the TR expressed in the hepatocyte and that stimulation of T 3 -sensitive neurones in the hypothalamus may also modulate hepatic glucose production via sympathetic projections to the liver, independently of circulating gluco-regulatory hormones. Also, there is close interaction between the thyroid and adrenal axes in chickens. The probiotic might possess the physiological role of enhancing the activity of corticotrophin releasing factor (CRF), which is known to stimulate thyrotropin secretion and, hence, T 4 secretion [18, 19] . Also, the levels of thyroid stimulating hormone (TSH) were increased in the probiotic-supplemented groups. This increase in TSH levels was attributed to the probiotic-enhanced activity of thyroid stimulating hormonereleasing hormone (TSH-RH) from the hypothalamus, thus, stimulating the release of TSH from thyrotropes of the anterior pituitary. Important factors that may be responsible for the decrease in T 4 levels include the number of receptors available for hormone binding and the type and efficiency of thyroid hormone transporters present in broiler chickens. Decreased T 3 levels were linked to a possible decline in type I deiodinase enzyme activity in peripheral tissue; this enzyme is responsible for the conversion of prohormone T 4 to metabolically active T 3 . Therefore, thyroid hormones stimulate the synthesis of many structural proteins, enzymes and hormones and thus play an important role in preadolescent growth and development. All these physiologic processes are enhanced by dietary probiotic supplementation in broiler chickens. Interestingly, this probiotic may serve as one of the co-regulators of thyroid hormone (TH) action. This finding further confirms the role of the yeast Saccharomyces cerevisiae as an excellent system in which to study thyroid hormone receptor action [32] . Klein et al. [25] reported that soy protein isolate had no effect on T 3 and free T 3 , but significantly decreased T 4 compared with casein in rats. The decrease in T 4 concentration may be responsible for the cholesterol-lowering effect of Saccharomyces cerevisiae, since T 3 is responsible for the maintenance of cholesterol homeostasis in the vascular endothelial lining [40, 59] .
Serum cholesterol and triglycerides: Cholesterol concentrations exhibited a marginal decrease in the probiotic supplemented groups with the exception of experimental group E 1 0.5%. The results of the present study are in agreement with those obtained by Panda et al. [41] showing that a probiotic caused a reduction in the level of serum and yolk cholesterol, but increased egg production. Probiotic supple-mentation may also depress the concentration of cholesterol in blood and yolk [35] . Also, a similar hypocholesterolemic effect was observed in broiler chickens supplemented with beta-fructans from chicory as source of prebiotic [66] . Low cholesterol concentrations in the present study may be due to the incorporation of cholesterol into the cellular membrane of the organism by the probiotic; thus, cholesterol assimilation by Lactobacillus in turn reduces cholesterol absorption in the system [20] . The cholesterol-lowering effect may also be due to deconjugation of bile salts, which are less soluble at lower pH and, thus, less absorbed in the gastro-intestinal tract. This results in huge fecal excretion of bile acids, which in turn lowers cholesterol in the body pool, as cholesterol constitutes the precursor of bile salts [24] . Krasowska et al. [27] reported that Saccharomyces strains are able to remove cholesterol from the growth medium and that the baker's yeast S. cerevisiae seems to be the perfect organism for lowering cholesterol in the gastrointestinal tract. Probiotics may also influence the cholesterol blood levels by mitigating cholesterol synthesis [15] . Interestingly, the decrease in the concentrations of HDL-cholesterol observed in the present study was significant, even though the probiotic had no effect on the concentrations of LDL-cholesterol and triglycerides. The decrease in HDL levels is due to the high carbohydrate diet, which has been reported to cause a decrease in HDL (Ernst et al. [13] ). This is contrary to the observations made by Panda et al. [42] , who reported that the probiotic increased the HDL levels at the expense of LDL. Also, products of bacterial fermentation, specifically short chain fatty acids, may inhibit cholesterol synthesis in the liver and/or mobilize plasma cholesterol to the liver [47] . High-density lipoproteins form a class of lipoproteins that vary somewhat in size (8 to 11 nm in diameter). The lipoproteins carry fatty acids and cholesterol from the body's tissue to the liver. They help to prevent a buildup of cholesterol by taking excess cholesterol away and are therefore referred to as "good" cholesterol. Blake et al. [7] reported that an increase in lipid level, particularly that of LDL-cholesterol, is predictive for coronary events such as atherosclerosis and coronary heart disease.
